| 000 | 01413 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514205814.0 | ||
| 264 | 0 | _c20050324 | |
| 008 | 200503s 0 0 pol d | ||
| 022 | _a1426-9686 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLebensztejn, Dariusz Marek | |
| 245 | 0 | 0 |
_a[The HBeAg/antiHBe seroconversion as a result of lamivudine treatment in children with chronic hepatitis B unresponsive to previous interferon alpha therapy]. _h[electronic resource] |
| 260 |
_bPolski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego _cJun 2004 |
||
| 300 |
_a557-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B Antibodies _xblood |
| 650 | 0 | 4 |
_aHepatitis B e Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 |
_aLamivudine _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSkiba, Elzbieta | |
| 700 | 1 | _aSobaniec-Lotowska, Maria | |
| 700 | 1 | _aKaczmarski, Maciej | |
| 773 | 0 |
_tPolski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego _gvol. 16 _gno. 96 _gp. 557-9 |
|
| 999 |
_c15199743 _d15199743 |
||